Clinical Report: Selective Exclusion of Post-Surgical Neck Radiation in Certain pN0 Patients with Advanced Oral Cavity Squamous Cell Carcinoma

Overview

This study evaluates the outcomes of pT3–T4 pN0 oral cavity squamous cell carcinoma patients treated with surgery and postoperative radiotherapy limited to the primary tumor bed, omitting neck irradiation.

Background

Oral cavity squamous cell carcinoma (OSCC) is a prevalent malignancy with a poor prognosis, particularly in advanced stages. Standard treatment typically involves surgical resection and neck dissection, with postoperative radiotherapy recommended for certain high-risk features. The necessity of postoperative neck irradiation in pathologically node-negative patients remains a topic of debate due to associated toxicities.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

• Postoperative neck irradiation (NI) is traditionally used to mitigate the risk of residual disease but is associated with significant toxicities.
• High-quality neck dissection (ND) with retrieval of ≥ 18 lymph nodes is critical for assessing the risk of occult nodal disease.
• Emerging cohort studies suggest that selective omission of postoperative NI in pN0 patients may not compromise oncological outcomes.
• Recent guidelines indicate that adjuvant neck radiotherapy should not be administered to pN0 patients without specific adverse findings.
• Further research is needed to identify which patients may safely avoid postoperative neck irradiation.

Clinical Implications

Clinicians should evaluate the quality of neck dissection and individual patient risk factors when determining postoperative treatment plans.

Conclusion

This study contributes to the ongoing discussion regarding the management of postoperative care in pN0 OSCC patients.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. Author(s)/Org, Source, Year -- Title
6. Author(s)/Org, Source, Year -- Title
7. Author(s)/Org, Source, Year -- Title
8. Author(s)/Org, Source, Year -- Title
9. Author(s)/Org, Source, Year -- Title
10. Author(s)/Org, Source, Year -- Title
11. Author(s)/Org, Source, Year -- Title
12. the asco post — Perioperative Pembrolizumab Plus Surgery and Risk-Adapted Standard Adjuvant Therapy Shows Benefit in Locally Advanced Head and Neck Cancer
13. NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025 - PubMed
14. Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline | Journal of Clinical Oncology
15. Delineation of the post-operative primary tumour and nodal clinical target volumes in oral cavity squamous cell carcinoma: European Society for Radiotherapy and Oncology (ESTRO) clinical guidelines - PubMed
16. Postoperative radiotherapy for oral cavity cancer with or without elective neck radiotherapy of the pN0 en bloc dissected neck: oncologic outcomes and late toxicity - PubMed
17. Elective neck irradiation does not improve regional control or survival in pT3–T4N0 oral cavity SCC after high–yield neck dissection: A retrospective multicenter analysis - ScienceDirect
18. Safe Omission of Postoperative Neck Irradiation in Selected pN0 Patients With Locally Advanced Oral Cavity Squamous Cell Carcinoma - PubMed
19. Omission of elective neck irradiation in pT3-T4 oral squamous cell carcinoma with a pN0 neck: Impact on regional control and overall survival. | Journal of Clinical Oncology
20. Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer | New England Journal of Medicine